Dupilumab Improves AD Affecting the Hands, Feet : vimarsana.

Dupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis.

Related Keywords

Oregon , United States , American , Ericl Simpson , , Oregon Health Science University In Portland , Journal Of The American Academy Dermatology , Foot Investigator , Global Assessment , Peak Pruritus Numeric Rating Scale , Oregon Health , Science University , American Academy , Dermatitis , Hands , Foot , Feet , Atopic Dermatitis , Atopic Eczema , Adolescent Medicine , Teens , Eenage , Teenager , Adolescent Health , Adolescents , Adolescent , Quality Of Life , Pol , Ealth Related Quality Of Life , Rqol , Pruritus , Pruritis , Pitch , Sleep , Pain Management , Allergic Contact Dermatitis , Contact Dermatitis , Eczema , Spain ,